Carlos Capela
About
In The Last Decade
Carlos Capela
16 papers receiving 382 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Infectious Diseases 196
- Neurology 93
- Epidemiology 81
- Molecular Biology 62
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by Carlos Capela
This map shows the geographic impact of Carlos Capela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Capela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Capela more than expected).
Fields of papers citing papers by Carlos Capela
This network shows the impact of papers produced by Carlos Capela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Capela. The network helps show where Carlos Capela may publish in the future.
Co-authorship network of co-authors of Carlos Capela
This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Capela. A scholar is included among the top collaborators of Carlos Capela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Capela. Carlos Capela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia breakdown → | 246 |
| 3 | 16 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 29 | |
| 7 | 11 | |
| 8 | 39 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 4 | |
| 13 | 1 | |
| 14 | 23 | |
| 15 | 1 | |
| 16 | Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report. | 10 |
| 17 | 1 | |
| 18 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.